CoChat

Targeting Ceramide Synthesis to Reverse Insulin Resistance

Open access
Schmitz-Peiffer, Carsten · 2010 · Diabetes
Cited by 62

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Insulin resistance is a key feature of type 2 diabetes, and the strong association between fat oversupply and defective insulin action in target tissues, especially skeletal muscle and liver, has motivated the search for intracellular lipid mediators that can interfere with insulin signaling and glucose homeostasis. Two of the best-studied candidates are diacylglycerol (DAG) and ceramide (1–3), to the extent that the tissue levels of these intermediate species are now routinely measured in models of insulin resistance and in human studies. Correlative evidence for their roles has accumulated over the last 10–15 years, but unfortunately, there are now several conflicting reports concerning the relative importance of these molecules (4–7). To resolve this situation, it is necessary to go beyond descriptive studies in order to address causation and elucidate the mechanisms involved. In the case of ceramide, the inhibitor myriocin is proving to be a useful tool. This fungal metabolite is a potent and specific blocker of serine palmitoyltransferase (SPT), the first enzyme in the pathway of de novo ceramide synthesis (8). By reducing the condensation of serine with palmitoyl-CoA to form 3-ketosphinganine (Fig. 1), the inhibitor is able to decrease ceramide synthesis without elevating intermediates such as sphinganine, which are upstream of ceramide formation and also have biological effects (9). Myriocin treatment of rats infused with different lipid cocktails for 6 h to induce insulin resistance in an acute fashion demonstrated that a reduction in ceramide accumulation in skeletal muscle could prevent defects in glucose disposal (10). Longer-term administration of the inhibitor was also able to improve glucose tolerance in genetically obese Zucker diabetic fatty (ZDF) rats and fat-fed mice. Finally, this study also supported the conclusion, drawn from in vitro work (11), that saturated fatty acids contribute to ceramide accumulation, whereas unsaturated fatty acids induce …

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/db10-0912

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 62

Metadata

Authors
Schmitz-Peiffer, C.
Venue
Diabetes
Published
2010-10-01
Volume
59
Issue
10
Pages
2351-2353
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2073053958
Cited by
62
References
5
FWCI
2.60
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.